Literature DB >> 26684623

Yiqi Wenyang Fang ameliorates allergic rhinitis through inhibiting inflammatory response and promoting the expression of Foxp3.

Jun Shi1, Yu Liu2, Shihai Yan1, Daonan Yan3.   

Abstract

Allergic rhinitis (AR) is an inflammatory disease with a hypersensitivity response to environmental stimulus. The aim of this study was to evaluate the effect of Yiqi Wenyang Fang (YWF) on AR and investigate the underlying mechanism. A total of 48 female Sprague-Dawley rats were randomly divided into six groups (normal control, model control, YWF at low dose, YWF at median dose, YWF at high dose, and loratadine). Rats were injected with antigen for sensitization. Then, rats in the YWF groups were treated with different dose of YWF for 28 days. Loratadine was used as a positive control. Number of sneezes, degree of runny nose, nasal rubbing movements, and tissue damage were scored. The protein and mRNA expression of Foxp3 were determined by western blot and real time-PCR analysis, respectively. Flow cytometry was used to detect the number of CD4+CD25+Foxp3+ Treg cells. The content of interleukin (IL)-10, transforming growth factor β1 (TGF-β1), IL-13, and IL-4 in the serum were detected by enzyme-linked immunosorbent assay (ELISA). Scores of symptoms were significantly reduced and nasal mucosa damage was alleviated after YWF administration. YWF increased the expression of Foxp3, IL-10, TGF-β1, and number of CD4+CD25+Foxp3+ Treg cells which were reduced by antigen injection. The expression levels of IL-13 and IL-4 were increased after antigen administration while decreased after YWF treatment. YWF may ameliorate AR through inhibiting inflammatory response and promoting Foxp3 expression.
© The Author(s) 2015.

Entities:  

Keywords:  Foxp3; Yiqi Wenyang Fang; allergic rhinitis; cytokines; inflammatory response

Mesh:

Substances:

Year:  2015        PMID: 26684623      PMCID: PMC5806833          DOI: 10.1177/0394632015621769

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  36 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis.

Authors:  Charles H Feng; Michaela D Miller; Ronald A Simon
Journal:  Am J Rhinol Allergy       Date:  2012 May-Jun       Impact factor: 2.467

3.  Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction.

Authors:  Lourdes Arruvito; Marianela Sanz; Alison H Banham; Leonardo Fainboim
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

Review 4.  Sublingual immunotherapy.

Authors:  Anthony J Frew
Journal:  N Engl J Med       Date:  2008-05-22       Impact factor: 91.245

5.  Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.

Authors:  Jan L Brozek; Jean Bousquet; Carlos E Baena-Cagnani; Sergio Bonini; G Walter Canonica; Thomas B Casale; Roy Gerth van Wijk; Ken Ohta; Torsten Zuberbier; Holger J Schünemann
Journal:  J Allergy Clin Immunol       Date:  2010-09       Impact factor: 10.793

6.  Intranasal heparin reduces eosinophil recruitment after nasal allergen challenge in patients with allergic rhinitis.

Authors:  C Vancheri; C Mastruzzo; F Armato; V Tomaselli; S Magrì; M P Pistorio; M LaMicela; L D'amico; N Crimi
Journal:  J Allergy Clin Immunol       Date:  2001-11       Impact factor: 10.793

Review 7.  Mechanism of traditional Chinese medicine in the treatment of allergic rhinitis.

Authors:  Hong Guo; Ming-ping Liu
Journal:  Chin Med J (Engl)       Date:  2013-02       Impact factor: 2.628

8.  Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis.

Authors:  Paul Chervinsky; Thomas Casale; Robert Townley; Ita Tripathy; Simon Hedgecock; Angel Fowler-Taylor; Henry Shen; Howard Fox
Journal:  Ann Allergy Asthma Immunol       Date:  2003-08       Impact factor: 6.347

9.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  Pharmacokinetics, intestinal absorption and microbial metabolism of single platycodin D in comparison to Platycodi radix extract.

Authors:  Jinjun Shan; Jiashuang Zou; Tong Xie; An Kang; Wei Zhou; Haishan Deng; Yancao Mao; Liuqing Di; Shouchuan Wang
Journal:  Pharmacogn Mag       Date:  2015 Oct-Dec       Impact factor: 1.085

View more
  1 in total

1.  Difference between CD25+Tregs and Helios+Tregs in a murine model of allergic rhinitis.

Authors:  Yun-Xiu Wang; Zhao-Wei Gu; Zhi-Wei Cao
Journal:  Braz J Otorhinolaryngol       Date:  2020-01-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.